From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA Allows Trial of Renal Denervation System to Begin

from Healio

Medtronic announced that the Food and Drug Administration has allowed the company to begin an investigational device exemption trial of a renal denervation system for treatment of hypertension in patients already taking antihypertensive medications. The system (Symplicity Spyral, Medtronic) will be tested in the SPYRAL HTN-ON MED trial, a prospective, randomized, sham-controlled study of up to 340 patients for up to three years, according to a press release issued by the company. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063